Welcome to our dedicated page for MOBIX LABS SEC filings (Ticker: MOBX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Mobix Labs, Inc. filings document the public-company disclosures of a fabless semiconductor and connectivity company serving defense, aerospace, telecommunications and other high-reliability markets. Registration statements and prospectus materials cover Class A common stock offerings, resale registration matters and financial disclosures tied to its capital needs.
Material-event reports cover securities purchase agreements, a senior secured convertible promissory note, registration rights, the completed reverse stock split of Class A and Class B common stock, and related adjustments to equity plans and outstanding securities. Proxy and annual meeting filings describe director elections, stockholder voting matters, bylaw amendments, quorum requirements and other governance provisions.
Mobix Labs, Inc. registers the resale of up to 24,127,116 shares of Class A Common Stock by selling stockholders. The resale prospectus covers Offered Securities held by third parties (including 1,268,252 Warrant Shares and 3,856,854 RaGE consideration shares) and states the company will not receive proceeds from resale by the Selling Stockholders.
The prospectus discloses 101,072,226 shares of Class A Common Stock outstanding as of January 31, 2026. It also states that, if certain warrants are exercised for cash, the company would receive aggregate gross proceeds of approximately $15.6 million. The filing warns that the Offered Securities would represent approximately 23.9% of outstanding Class A shares as of January 31, 2026 and that such sales could materially depress the market price.
Mobix Labs, Inc. is asking stockholders to approve four key items at its 2026 virtual annual meeting. Investors will vote on electing Class II directors, ratifying PricewaterhouseCoopers LLP as auditor for the year ending September 30, 2026, and a reverse stock split.
The reverse split would reclassify and combine outstanding Class A and Class B shares at a ratio between 1:10 and 1:50, at the Board’s discretion, primarily to help regain compliance with Nasdaq’s $1.00 minimum bid price after a prior deficiency notice and extension through April 27, 2026.
Stockholders are also asked to approve, under Nasdaq Listing Rule 5635(d), potential issuance of up to 8,229,701 Class A shares on exercise of an Inducement Warrant, 384,053 shares on Placement Agent Warrants, and 1,000,000 shares on an additional warrant related to amended outstanding warrants.
Mobix Labs, Inc. announced that its board of directors approved an amendment and restatement of the company’s bylaws effective February 27, 2026. The key change lowers the quorum requirement for stockholder meetings from a majority of voting power to one-third of the voting power of outstanding shares entitled to vote, unless otherwise required by law, the certificate of incorporation or applicable stock exchange rules.
The full text of the amended and restated bylaws, including the revised quorum language in Section 1.5, is provided as Exhibit 3.1 to this report.
Mobix Labs, Inc. is soliciting votes at its 2026 Annual Meeting to elect directors, ratify PricewaterhouseCoopers LLP, approve a reverse stock split at a ratio between 1-for-10 and 1-for-50, and approve in accordance with Nasdaq Rule 5635(d) the issuance of up to 8,229,701, 384,053, and 1,000,000 shares of Class A Common Stock upon exercise of specified warrants.
Illustrative share counts as of January 31, 2026 show 101,072,226 shares of Class A Common Stock outstanding and 2,004,901 shares of Class B Common Stock outstanding; the reverse split would proportionally reduce outstanding shares within the approved ratio range.
Mobix Labs, Inc. is registering the resale of up to 24,127,116 shares of its Class A Common Stock for existing selling stockholders. The company itself is not selling shares and will receive no proceeds from these resales.
The registered shares include stock issued in financings and acquisitions, such as 16,161,787 warrant shares and 3,856,854 shares issued for the RaGE Systems acquisition. As of January 31, 2026, Mobix had 101,072,226 Class A and 2,004,901 Class B shares outstanding.
Mobix may receive up to approximately $15.6 million in gross cash proceeds only if certain outstanding warrants covered by this registration are exercised for cash. The filing emphasizes that the registered block is large, representing about 23.9% of Class A shares, and that resales, or expectations of resales, could significantly pressure the stock price.
MOBIX LABS ownership disclosure: Armistice Capital, LLC and Steven Boyd report beneficial ownership of 3,377,508 shares of Common Stock, representing 4.99% of the class as of 12/31/2025. The filing states Armistice Capital exercises voting and investment power over the shares held by Armistice Capital Master Fund Ltd.
The reporting persons file jointly under Rule 13d-1(k) and note the Master Fund has the right to receive dividends or sale proceeds. Signatures are dated 02/17/2026.
Mobix Labs, Inc. reported a net loss of $10.1 million for the three months ended December 31, 2025, narrower than the $19.8 million loss a year earlier. Revenue fell to $1.9 million from $3.2 million, with both product and services sales declining.
Gross profit dropped to $0.6 million, and interest expense increased to $1.4 million as total debt reached $6.3 million. Despite lower operating expenses, especially stock-based compensation, the company ended the quarter with only $0.3 million in cash, prompting a going concern warning about its ability to meet obligations over the next year.
Stockholders’ equity improved to $4.7 million from a deficit at September 30, 2025, helped by share issuances and warrant reclassification. After quarter-end, Mobix raised approximately $5.1 million net through a public offering of 30 million Class A shares at $0.20 each and issued additional make-whole shares to a lender.
Mobix Labs CEO Philip Sansone filed a Form 4 showing an automatic tax-related sale of shares. On February 2, 2026, Sansone sold 87,025 shares of Mobix Labs Class A common stock at a weighted-average price of $0.188 per share in a transaction coded as a sale.
According to the disclosure, the shares were sold solely to cover taxes arising from restricted stock units that vested on January 31, 2026, under a pre‑set “sell to cover” election, meaning the trades were not discretionary. After this transaction, Sansone directly beneficially owned 1,848,816 shares of Mobix Labs.
Mobix Labs, Inc. insider activity is disclosed in a Form 144 notice covering planned sales of common stock. The filing shows an intention to sell 87,025 shares of common stock through J.P. Morgan Securities LLC on NASDAQ, with an aggregate market value of 16,360.04 and 58,624,989 shares outstanding.
The seller, Philip Sansone, previously acquired 200,000 common shares on 01/31/2026 via RSU vesting from Mobix Labs, Inc. as equity compensation, with payment dated 02/03/2026. Over the prior three months, he sold 100,044 common shares for gross proceeds of 41,219.83 on 11/21/2025.
Mobix Labs, Inc. received an amended Schedule 13G/A showing that Vernon Davis Grizzard III and Sage Hill Investors, LLC together beneficially own 3,142,857 shares of its Class A common stock, representing 4.9% of the class as of December 31, 2025.
The reporting persons have sole voting power over 3,142,857 shares and sole dispositive power over 1,642,857 shares, with no shared voting or dispositive power. They certify that the securities were not acquired and are not held for the purpose of changing or influencing control of Mobix Labs.